JNJ holder plans Rule 144 sale of 100K shares

A holder of JNJ common stock filed a notice of proposed sale of 100,000 shares under Rule 144.

Rhea-AI Filing Summary

A holder of JNJ common stock filed a notice of proposed sale of 100,000 shares under Rule 144. The shares are to be sold through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $22,014,000 based on the figures in the notice. As context, the filing lists 2,409,295,102 JNJ common shares outstanding. The planned sale date is approximately 01/26/2026.

The 100,000 shares of common stock were acquired on 03/18/2025 via a transfer from Joaquin Duoto, who originally received the shares as compensation between 02/12/2021 and 02/13/2023. The form also includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many JNJ shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 100,000 shares of JNJ common stock.

What is the approximate market value of the JNJ shares to be sold?

The filing lists an aggregate market value of $22,014,000 for the 100,000 JNJ common shares to be sold.

When is the planned sale date for the JNJ shares in this Form 144?

The approximate date of sale given in the notice is 01/26/2026.

How many JNJ shares are listed as outstanding in this Form 144 notice?

The form states there are 2,409,295,102 JNJ common shares outstanding.

How and when were the JNJ shares in this Form 144 acquired?

The 100,000 JNJ common shares were acquired on 03/18/2025 via a transfer from Joaquin Duoto, who obtained them as compensation between 02/12/2021 and 02/13/2023.

Which broker is handling the proposed JNJ share sale under this Form 144?

The proposed sale will be handled by J.P. Morgan Securities LLC, located at 270 Park Avenue, 10th Floor, New York, NY 10017.

Does the Form 144 filer make any representation about undisclosed adverse information on JNJ?

Yes. By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/26/2026 - 04:57 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001673401
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Johnson & Johnson
SEC File Number	001-03215
Address of Issuer	One Johnson & Johnson Plaza New Brunswick NEW JERSEY 08933
Phone	732-524-0400
Name of Person for Whose Account the Securities are To Be Sold	Joaquin Duato
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	CEO, Chariman

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Avenue, 10th Floor New York NY 10017	100000	22014000	2409295102	01/26/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/18/2025	Transfer	Joaquin Duoto, who acquired the shares via compensation between 02/12/21 and 02/13/23			100000	03/18/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares covered by this filing will be sold by Almudena Becher, spouse of Joaquin Duato.
Date of Notice	01/26/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Joaquin Duato
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)